britishcarfreak said:Correct me if I'm wrong but I thought CSIRO were handling their patent issues for them. This raises the question of how is that funded? And, how hard will they go to fight for it?
There is speculation that this patent family dispute could lead to loss of the Graham patent and this could be pretty bad for deals - although not the end of the world.
Anyone following the stock already should have known that this stuff was still in question - I certainly knew - that's why I didn't jump to post anything about it a few days ago - and that's why I continued to hold.
Ken said:I have a small holding that i bought at 20.5 cents.
Where will support lie for BLT?
Is the stock finished are we heading back to 2 cents... or has there been to much progress for that?
I want to get more, but dont know what price to get them at.
Are we going sub tens again?
It's called a stop-loss for a reason, I figured a ~40% drop in share price was enough to cut & run. I didn't have much skin in the game, so my loss wasn't particularly painful, I'll put it down to "education" and move on.britishcarfreak said:I'll vomit if the SP goes much below 10c.
Ken said:my strategy with BLT is to accumulate.
Its disappointing the share price has dropped but is it opportunity for going long on this?
I was not aware about BLT untill the start of the month.
I am a lot happier buying at current levels than at 20 cents plus.
When BLT makes or breaks, it will either be a long way ahead of 13 cents or a long way down....
sydneysider said:Patent issues/rejections at the US patent office will require deep pockets to overcome or challenge. BLT does not have the funds to fight thru these issues nor the inordinate amount of time that it will take. The lousy action in the share price vs. the "glowing" presentation by BLT on their website were somewhat discordant. The fact that they did not make this stuff known at their recent shareholders meeting AND the issue of zillions of shares at a few cents is now explainable in hindsight. IF u do not understand biotechs then stay away from them.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?